Clinical Trials Logo

Clinical Trial Summary

1. Research question Can a web-based nutritional educational intervention improve phosphorus knowledge and control of phosphorus intake?

2. Experimental design

Following enrollment and informed consent, subjects will be randomized to one of two arms (group1: usual care; group 2: usual care plus Internet-based nutrition module). All subjects will undergo baseline data collection, consisting of:

1. Short form of the test of functional health literacy in adults: categorizes individuals as having adequate, marginal or inadequate health literacy.

2. Chronic Kidney Disease (CKD) Knowledge Assessment Tool: addresses nutritional knowledge of CKD.

3. SF-12 Health Survey version 2: a 12-item measure of health related quality of life.

4. Kidney Disease Self-Management Survey: a 58-item Likert scale based on theories important for self-management in chronic disease.

5. 3-Day Dietary Diaries

6. Lab work:

i. Serum phosphorus, calcium and parathyroid hormone levels. ii. Circulating endothelial cells, a novel marker for vascular damage.

Following baseline data collection, group 1 will continue with their scheduled clinic visit, while group 2 will spend approximately 30 minutes completing a web-based nutrition module. After completion of the module, patients will proceed with their scheduled clinic visit.

All subjects will then be asked to return in 30-60 days to repeat some of the survey information and blood work

3. Major risks to subjects There is the potential for some mild discomfort from the necessary blood draws, which occur twice per subjects.

4. Potential benefits to subjects Subjects randomized to the web-based module may receive an educational benefit from it.

5. Consent procedures Only individuals who can provide their own consent can participate. Upon agreeing to enroll, a study coordinator or investigator will provide the subject with a copy of the consent form, and will remain available to answer any questions.


Clinical Trial Description

Specific Aim 1: To examine the effect of a novel, web-based method of educating CKD patients on patient knowledge and dietary intake of phosphorus. We will compare 2 methods for educating CKD patients about dietary phosphorus intake:

1. Usual care, consisting of individualized care/counseling by a nephrologist.

2. Usual care, plus review of the Kidney School (KS) Nutrition Module (see below). To compare gains in phosphorus knowledge after 1 month. To compare compliance with dietary phosphorus intake, as measured by mineral metabolism laboratory values (serum phosphorus, calcium, PTH, calcium-phosphorus product) and 3-day dietary diaries.

Specific Aim 2: To determine if the S-TOFHLA predicts CKD patients' knowledge and compliance with recommended dietary phosphorus intake:

1. To measure health literacy in patients undergoing maintenance hemodialysis, using the S-TOFHLA.

2. To assess correlations between health literacy and knowledge of phosphorus.

3. To assess correlations between health literacy and compliance with CKD dietary phosphorus guidelines, as measured by mineral metabolism laboratory values (serum phosphorus, calcium, PTH, calcium-phosphorus product), and dietary phosphate intake, as measured by 3-day dietary diaries.

4. To assess correlations between health literacy and compliance with CKD dietary phosphorus guidelines, following usual care versus an eHealth nutrition intervention.

Specific Aim 3: To determine if higher dietary phosphorus intake correlates with higher levels of CECs.

1. To measure CEC levels in patients with CKD.

2. To assess correlations between dietary phosphorus intake, serum phosphorus levels, and CECs in patients with CKD. ;


Study Design

N/A


Related Conditions & MeSH terms


NCT number NCT00693277
Study type Interventional
Source University of Wisconsin, Madison
Contact
Status Withdrawn
Phase N/A
Start date September 2006
Completion date September 2008

See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1